TORONTO DOMINION BANK - BRIDGEBIO PHARMA, INC. ownership

BRIDGEBIO PHARMA, INC.'s ticker is and the CUSIP is 10806XAC6. A total of 2 filers reported holding BRIDGEBIO PHARMA, INC. in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of BRIDGEBIO PHARMA, INC.
ValueSharesWeighting
Q2 2021$2,436,000
+6.7%
2,500,000
-33.7%
0.00%0.0%
Q1 2021$2,283,0003,768,9000.00%
Other shareholders
BRIDGEBIO PHARMA, INC. shareholders Q1 2021
NameSharesValueWeighting ↓
Nuveen Asset Management, LLC 15,000,000$14,334,0000.01%
TORONTO DOMINION BANK 3,768,900$2,283,0000.00%
View complete list of BRIDGEBIO PHARMA, INC. shareholders